Status:
RECRUITING
The Role of Laryngopharyngeal Reflux in IPF
Lead Sponsor:
National Jewish Health
Conditions:
IPF
Reflux
Eligibility:
All Genders
40-95 years
Brief Summary
The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in ...
Detailed Description
The study team hypothesizes the SGI will correlate more strongly with measures of IPF severity (at baseline and over time) than gastroesophageal reflux (GER) data derived from the esophageal detector ...
Eligibility Criteria
Inclusion
- Diagnosis of IPF
- Age 40-95
- Able to read, speak, and understand English
- If subjects are currently taking medication for reflux or GERD, they much be on a stable does for at least 4 weeks prior to consent.
Exclusion
- Patients who do not meet all inclusion criteria
- Pregnant females
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03418350
Start Date
August 1 2018
End Date
December 1 2026
Last Update
November 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Jewish Health
Denver, Colorado, United States, 80206